Friday, 25 September 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 1, 2026

Best CBD Gummies 2026 Consumer Report: Full Spectrum Formulations, Lab Testing Standards, and State Legal Requirements Examined in Consumer Wellness Category Analysis

View original at globenewswire.com
Best CBD Gummies 2026 Consumer Report: Full Spectrum Formulations, Lab Testing Standards, and State Legal Requirements Examined in Consumer Wellness Category Analysis LOS ANGELES, CA, Jan…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Entourage Effect theory that cannabinoids work differently together versus isolated is not definitively established

    80% confidence

  • No evidence of recreational use of CBD or any public health-related problems associated with use of pure CBD

    80% confidence

  • Existing regulatory frameworks for foods and dietary supplements deemed not appropriate for cannabidiol

    80% confidence

  • No CBD products evaluated by FDA for safety or efficacy as supplements

    80% confidence

  • No full spectrum CBD product can guarantee drug test outcomes

    80% confidence

  • Product uses cold-pressed, unrefined CBD extraction with CO2 extraction technology and triple filtration technology for THC processing

    80% confidence

  • CBD is generally well tolerated with a good safety profile

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com
Best CBD Gummies 2026 Consumer Report: Full Spectrum Formulations, Lab Testing Standards, and State Legal Requirements Examined in Consumer Wellness Category Analysis — Source | Via News | ViaNews EU